Physician profile
Alexander Wu
NPI 1780619692
$1,115.13
in general payments reported to CMS, 2019-2025
14 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $19.40 · 2021: $140 · 2022: $204 · 2023: $298 · 2024: $41.92 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.78 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $477.81 | 2021-2025 | Argos, Hydrus Microstent |
| Takeda Pharmaceuticals U.S.A., INC. | $160.12 | 2019 | |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $68.05 | 2021-2025 | |
| Tersera Therapeutics LLC | $65.71 | 2019 | |
| Biotissue Holdings INC. | $65.32 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $35.44 | 2022 | |
| Rigel Pharmaceuticals, INC. | $27.85 | 2022 | |
| Seagen INC. | $26.00 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $24.82 | 2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Abbvie INC. | $19.81 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $13.73 | 2022 | |
| Allergan, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.